Phenotypic Changes During Blast Crisis of CML Characterized by Occurrence and Loss of TDT

  • Elisabeth Paietta
  • Josef D. Schwarzmeier
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 145)


Phenotypic changes in a case of blast crisis of chronic myelogenous leukemia (CML-BC) were characterized by serial terminal transferase determinations simultaneously related to morphological, cytochemical, and cytogenetic data.


White Blood Cell Count Chronic Myelogenous Leukemia Blast Cell Terminal Deoxynucleotidyl Transferase Blast Crisis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Boyum, A., 1968, Isolation of mononuclear cells and granulocytes from human blood, Scand. J. Clin. Lab. Invest., 21 (Suppl. 97):77Google Scholar
  2. Hutton, J.J., and Coleman, M.S., 1976, Terminal transferase measurement in the differential diagnosis of adult leukemias, Br. J. Hematol., 34:447CrossRefGoogle Scholar
  3. Janossy, G., Woodruff, R.K., Paxton, A., Greaves, M.F., Capellaro, D., Kirk, B., Innes, E.M., Eden, O.B., Levis, C., Catovsky, D., and Hoffbrand, A.V., 1978, Membrane marker and cell separation studies in Phi positive leukemia. Blood, 51:861PubMedGoogle Scholar
  4. Janossy, G., Woodruff, R.K., Pippard, M.J., Prentice, G., Hoffbrand, A.v., Paxton, A., Lister, T.A., Bunch, C., and Greaves, M.F., 1979, Relation of “lymphoid” phenotype and response to chemotherapy incorporating vincristine-prednisone in the acute phase of Phi positive leukemia. Cancer. 43:426PubMedCrossRefGoogle Scholar
  5. Kung, P.C., Long, J.C., McCaffrey, R.P., Latliff, R.L., Harrison, T.A., and Baltimore, D., 1978, Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma, Am. J. Med., 64:788PubMedCrossRefGoogle Scholar
  6. Marks, S.M., Baltimore, D., and McCaffrey, R., 1978, Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia, N. Engl. J. Med., 298:812PubMedCrossRefGoogle Scholar
  7. Mertelsmann, R., Mertelsmann, I., Koziner, B., Moore, M.A.S., and Clarkson, B.D., 1978, Improved biochemical assay for terminal deoxynucleotidyl transferase in human blood cells: Results in 89 adult patients with lymphoid leukemias and malignant lymphomas in leukemic phase. Leuk. Res., 2:57CrossRefGoogle Scholar
  8. Modak, M.J., Mertelsmann, R., Koziner, B., Pahwa, R., Moore, M.A.S., Clarkson, B.D., and Good, R. A., 1980, A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias, J Cancer Res. Clin. Oncol., 98:91PubMedCrossRefGoogle Scholar
  9. Ross, D.D., Wiernik, P.H., Sarin, P.S., and Whang-Peng, J., 1979, Loss of terminal deoxynucleotidyl transferase (TdT) activity as a predictor of emergence of resistance to chemotherapy in a case of chronic rnyelogenous leukemia in blast crisis. Cancer. 44:1566PubMedCrossRefGoogle Scholar
  10. Sarin, P.S., Anderson, P.N., and Gallp, R.C., 1976, Terminal deoxynucleotidyl transferase activities in human blood leukocytes and lymphoblast cell lines: High levels in lymphoblast cell lines and in blast cells of some patients with chronic myelogenous leukemia in acute phase. Blood, 47:11PubMedGoogle Scholar
  11. Seabright, M., 1971, Rapid banding technique for human chromosomes. Lancet, ii:971CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Elisabeth Paietta
    • 1
  • Josef D. Schwarzmeier
    • 1
  1. 1.First Medical Dep.Univ. of Vienna, Medical SchoolViennaAustria

Personalised recommendations